Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis

Ayobami T Akenroye1, Anand A Kumthekar1, Michail K Alevizos1

  • 1Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, New York.

Insights

An electronic medical record reminder did not improve cardiovascular disease (CVD) risk screening for rheumatoid arthritis (RA) patients. Further research is needed to overcome barriers and educate on RA-related CVD risks.

Area of Science:

  • Rheumatology
  • Cardiology
  • Health Informatics

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality in rheumatoid arthritis (RA) patients.
  • Systematic CVD risk assessment is often inadequate in RA management.
  • Tertiary care centers face challenges in integrating CVD risk screening into routine RA care.

Purpose of the Study:

  • To evaluate the effectiveness of an electronic medical record (EMR)-based reminder system.
  • To assess the impact of EMR reminders on CVD risk screening by rheumatologists and primary care providers in RA patients.
  • To determine changes in lipid screening, blood pressure, and obesity rates post-intervention.

Main Methods:

  • An EMR-based reminder system was implemented in December 2013 for RA patients (ICD-9 code 714.0).
  • The reminder included key cardiovascular risk factors: body mass index, blood pressure, and lipid profiles.
  • Lipid screening rates, BP, and obesity were compared pre- and post-implementation; logistic regression identified screening predictors.

Main Results:

  • Lipid screening rates were 50% pre-implementation and 46% post-implementation (P=0.58), showing no significant improvement.
  • No significant improvements were observed in blood pressure or obesity rates after the EMR reminder implementation.
  • Older age and a history of diabetes mellitus were associated with higher odds of lipid screening post-intervention.

Conclusions:

  • The implemented EMR reminder did not enhance cardiovascular disease risk screening among rheumatoid arthritis patients.
  • Barriers to effective CVD screening in RA require further investigation.
  • Educational initiatives for patients and providers regarding RA-associated CVD risks are necessary.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
469
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
426
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
763
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
936
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567